Clinical Trials

A Phase 3 clinical trial shows that the Novavax vaccine has 90.4 percent efficacy in preventing symptomatic COVID-19

Clinical trials published in high-profile medical journals rarely report on key sociodemographic characteristics

Study links ALS to a fat manufacturing gene and maps out a genetic therapy

The first-in-human, Phase 1 trial will assess the safety and protection of a universal influenza vaccine

The gene therapy was safe and improved patients' vision, according to initial data from a clinical trial

Advantages of decentralized or virtual trials extend beyond the constraints posed by the COVID-19 pandemic

Survey identifies the key factors for retention in clinical research coordinator positions

Less than a third of COVID-19 trials are led by women, half the proportion observed in non-COVID-19 trials

If approved for use, it would be the first drug to delay or prevent Type 1 diabetes

First peer-reviewed real-world study of COVID-19 vaccine examined 600,000 vaccinated individuals